Lipopolysaccharides (LPSs) play a dual role as inflammation-inducing and as membrane-forming molecules. The former role attracts significantly more attention from scientists, possibly because it is more closely related to sepsis and septic shock. This review aims to focus the reader's attention to the other role, the function of LPS as the major constituent of the outer layer of the outer membrane of Gram-negative bacteria, in particular those of enterobacterial strains. In this function, LPS is a necessary component of the cell envelope and guarantees survival of the bacterial organism. At the same time, it represents the first target for attacking molecules which may either be synthesized by the host's innate or adaptive immune system or administered to the human body. The interaction of these molecules with the outer membrane may not only directly cause the death of the bacterial organism, but may also lead to the release of LPS into the circulation. Here, we review membrane model systems and their application for the study of molecular mechanisms of interaction of peptides such as those of the human complement system, the bactericidal/permeability-increasing protein (BPI), cationic antibacterial peptide 18 kDa (CAP18) as an example of cathelicidins, defensins, and polymyxin B (PMB). Emphasis is on electrical measurements with a reconstitution system of the lipid matrix of the outer membrane which was established in the authors' laboratory as a planar asymmetric bilayer with one leaflet being composed solely of LPS and the other of the natural phospholipid mixture. The main conclusion, which can be drawn from these investigations, is that LPS and in general its negative charges are the dominant determinants for specific peptide—membrane interactions. However, the detailed mechanisms of interaction, which finally lead to bacterial killing, may involve further steps and differ for different antibacterial peptides.
References
1.
Kawasaki S., Moriguchi R., Sekiya K. et al. The cell envelope structure of the lipopolysaccharide-lacking Gram-negative bacterium Sphingomonas paucimobilis. J Bacteriol1994; 176: 284—290.
2.
Nikaido H., Vaara M.Outer membrane. In: Neidhardt C, Ingraham JL, Brooks Low K , Magasanik B, Schaechter M, Umbarger HE. (eds) Escherichia coli and Salmonella typhimurium. Cellular and Molecular Biology . Washington, DC: American Society for Microbiology, 1987: 7—22.
3.
Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science1990; 249: 1429—1431.
4.
Schromm AB, Brandenburg K., Rietschel ETh, Flad H-D, Carroll SF, Seydel U. Lipopolysaccharide binding protein (LBP) mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett1996 ; 399: 267—271.
5.
Tapping RI, Gegner JA, Kravchenko VV, Tobias PSRoles for LBP and soluble CD14 in cellular uptake of LPS. Prog Clin Biol Res1998; 397: 73—78.
Gutsmann T., Müller M., Carroll SF, MacKenzie RC, Wiese A., Seydel U.Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun2001; 69: 6942—6950.
8.
Pfeiffer R.Untersuchungen über das Choleragift. Zf fur Hygiene1892; 11: 393—412.
9.
Lin J., Huang S., Zhang Q.Outer membrane proteins: key players for bacterial adaptation in host niches . Microbes Infect2002; 4: 325—331.
10.
Sen K., Hellman J., Nikaido H.Porin channels in intact cells of Escherichia coli are not affected by Donnan potentials across the outer membrane. J Biol Chem1988; 263: 1182—1187.
11.
Mueller P., Rudin DO, Tien HTReconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature1962; 194: 979—981.
12.
Tien HTBilayer Lipid Membranes (BLM): Theory and Practice. New York: Marcel Dekker, 1974.
13.
Montal M., Mueller P.Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad Sci USA1972; 69: 3561—3566.
Schindler H.Formation of planar bilayers from artificial or native membrane vesicles. FEBS Lett1980 ; 122: 77—79.
16.
Osborn MJ, Gander JE, Parisi E., Carson J.Mechanism and assembly of the outer membrane of Salmonella typhimurium . J Biol Chem1972; 247: 3962—3972.
17.
White SHThe physical nature of planar bilayer membranes. In: Miller C. (ed) Ion Channel Reconstitution . New York: Plenum, 1986: 3—35.
18.
Wiese A., Seydel U.Electrophysiological measurements on reconstituted outer membranes . Methods Mol Biol2000; 145: 355—370.
19.
Benz R., Janko K., Boos W., Läuger P.Formation of large, ion-permeable membrane channels by the matrix protein (porin) of Escherichia coli. Biochim Biophys Acta1978; 511: 305—319.
20.
Seydel U., Schröder G., Brandenburg K.Reconstitution of the lipid matrix of the outer membrane of Gram-negative bacteria as asymmetric planar bilayer. J Membr Biol1989; 109: 95—103.
21.
Babunashvili IN, Silberstein AY, Nenashev VADiscrete changes of conductance and capacitance of bimolecular lipid membranes induced by liposomes . Studia Biophys1981; 83: 131—137.
22.
Benz R., Janko K.Voltage-induced capacitance relaxation of lipid bilayer membranes. Effects of membrane composition. Biochim Biophys Acta1976; 455: 721—738.
23.
Latorre R., Hall JEDipole potential measurements in asymmetric membranes. Nature1976; 254: 361—363.
24.
Hall JE, Latorre R.Nonactin—K+ complex as a probe for membrane asymmetry. Biophys J1976; 15: 99—103.
25.
Schoch P., Sargent DF, Schwyzer R.Capacitance and conductance as tools for the measurement of asymmetric surface potentials and energy barriers of lipid bilayer membranes. J Membr Biol1979; 46: 71—89.
26.
Seydel U., Eberstein W., Schröder G., Brandenburg K.Electrostatic potential barrier in asymmetric planar lipopolysaccharide/phospholipid bilayers probed with the valinomycin—K+ complex. Z Naturforsch1992; 47c: 757—761.
27.
Wiese A., Reiners JO, Brandenburg K., Kawahara K., Zähringer U., Seydel U.Planar asymmetric lipid bilayers of glycosphingolipid or lipopolysaccharide on one side and phospholipids on the other: membrane potential, porin function, and complement activation. Biophys J1996; 70: 321—329.
28.
Struck DK, Hoekstra D., Pagano REUse of resonance energy transfer to monitor membrane fusion. Biochemistry1981; 20: 4093—4099.
29.
Schromm AB, Brandenburg K., Loppnow H. et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol1998 ; 161: 5464—5471.
30.
Wu P., Brand L.Resonance energy transfer: methods and applications. Anal Biochem1994; 218: 1—13.
31.
Mantsch HH, McElhaney RNPhospholipid phase transitions in model and biological membranes as studied by infrared spectroscopy. Chem Phys Lipids1991; 57: 213—226.
32.
Marcelja S.Chain ordering in liquid crystals. II. Structure of bilayer membranes. Biochim Biophys Acta1974; 367: 165—176.
33.
Blume A.A comparative study of the phase transition of phospholipid bilayers and monolayers . Biochim Biophys Acta1979 ; 557: 32—44.
34.
Schwarz G., Taylor SEThermodynamic analysis of the surface activity exhibited by a largely hydrophobic peptide. Langmuir1995; 11: 4341—4346.
35.
Morgan BPPhysiology and pathophysiology of complement: progress and trends . Crit Rev Clin Lab Sci1995; 32: 265—298.
Bhakdi S., Tranum-Jensen J.Damage of mammalian cells by proteins that form transmembrane pores . Rev Physiol Biochem Pharmacol1987; 107: 148—206.
39.
Esser AFThe membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology1994; 87: 229—247.
40.
Tranum-Jensen J., Bhakdi S., Bhakdi-Lehnen B., Bjerrum OJ, Speth V.Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand J Immunol1978; 7: 45—56.
41.
Tranum-Jensen J., Bhakdi S.Freeze-fracture ultrastructural analysis of the complement lesion. J Cell Biol1983; 97: 618—626.
42.
Tschopp J.Ultrastructure of the membrane attack complex of complement heterogeneity of the complex caused by different degree of C9 polymerization. J Biol Chem1984; 259: 7857—7863.
43.
Zhang Y., Suankratay C., Zhang X-H., Lint TF, Gewurz H.Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology1999; 42: 81—90.
44.
Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJMannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. J Infect Dis2001; 184: 836—845.
45.
Morrison DC , Kline LFActivation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol1977; 118: 362—368.
46.
Vukajlovich SW, Hoffman J., Morrison DCActivation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathway . Mol Immunol1987; 24: 319—331.
47.
Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MMStudies on the mechanism of bacterial resistance to complement-mediated killing I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med1982; 155: 797—808.
48.
Joiner KA, Hammer CH, Brown EJ, Frank MMStudies on the mechanism of bacterial resistance to complement-mediated killing II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane . J Exp Med1982; 155: 809—819.
Ward CK, Inzana TJResistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide. J Immunol1994; 153: 2110—2121.
51.
del Castillo J., Rodriguez A., Romero CA, Sanchez V.Lipid films as transducers for detection of antigen-antibody and enzyme-substrate reactions . Science1966; 153: 185—188.
52.
Barfort P., Arquilla ER, Vogelhut P.Resistance changes in lipid bilayers: immunological applications. Science1968; 160: 1119—1121.
53.
Wobschall D. , McKeon C.Step conductance increases in bilayer membranes induced by antibody-antigen-complement action. Biochim Biophys Acta1975; 413: 317—321.
54.
Michaels DW , Abramowitz AS, Hammer CH, Mayer MMIncreased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement. Proc Natl Acad Sci USA1976 ; 73: 2852—2856.
55.
Benz R., Schmid A., Wiedmer T., Sims PJSingle-channel analysis of the conductance fluctuations induced in lipid bilayer membranes by complement proteins C5b-9. J Membr Biol1986; 94: 37—45.
56.
Young Jde, Cohn ZA, Podack ERThe ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities . Science1986; 233: 184—190.
57.
Young Jde, Young TMChannel fluctuations induced by membrane attack complex C5b-9. Mol Immunol1990; 27: 1001—1007.
58.
Shiver JW, Dankert JR, Esser AFFormation of ion-conducting channels by the membrane attack complex proteins of complement. Biophys J1991; 60: 761—769.
59.
Jackson MB, Stephens CL, Lecar H.Single channel currents induced by complement in antibody-coated cell membranes . Proc Natl Acad Sci USA1981; 78: 6421—6425.
60.
Mountz JD, Tien HTBilayer lipid membranes (BLM): study of antigen—antibody interactions . J Bioenerg Biomembr1978; 10: 139—151.
61.
Vukajlovich SWAntibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to Re-chemotype lipopolysaccharide and purified lipid A. Infect Immun1986; 53: 480—485.
62.
Vukajlovich SW, Sinoway P., Morrison DCActivation of human serum complement by bacterial lipopolysaccharides. EOS J Immunol Immunopharmacol1986; 6 (Suppl. 3): 73—75.
63.
Mey A., Ponard D., Colomb M., Normier G., Binz H., Revillard J-P.Acylation of the lipid A region of Klebsiella pneumoniae LPS controls the alternative pathway activation of human complement. Mol Immunol1994; 31: 1239—1246.
64.
Clas F., Schmidt G., Loos M.The role of the classical pathway for the bactericidal effect of normal sera against Gram-negative bacteria. Curr Top Microbiol Immunol1985; 121: 19—72.
65.
Bjerre A., Brusletto B., Mollnes TE et al. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J Infect Dis2002; 185: 220—228.
66.
Schröder G. , Brandenburg K., Brade L., Seydel U.Pore formation by complement in the outer membrane of Gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers. J Membr Biol1990; 118: 161—170.
67.
Wiese A., Grünewald P., Schaper K-J., Seydel U.Influence of acyl chain fluidity on the lipopolysaccharide-induced activation of complement. J Endotoxin Res2001; 7: 147—154.
68.
Münstermann M., Wiese A., Brandenburg K. et al. Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes. J Membr Biol1999; 167: 223—232.
69.
Hesketh TR, Payne SN, Humphrey JHComplement and phospholipase C lysis of lipid membranes. Immunology1972; 23: 705—711.
70.
Devine DV, Wong K., Serrano K., Chonn A., Cullis PRLiposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta1994 ; 1191: 43—51.
71.
Oshima H., Soma G-I., Mizuno D.Gangliosides can activate human alternative complement pathway. Int Immunol1993; 5: 1349—1351.
72.
Elsbach P., Weiss J.Role of the bactericidal/permeability-increasing protein in host defence . Curr Opin Immunol1998; 10: 45—49.
73.
Elsbach P.The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukoc Biol1998; 64: 14—18.
Levy O., Elsbach P.Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis. Curr Infect Dis Rep2001; 3: 407—412.
76.
Weiss J., Olsson I.Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood1987; 69: 652—659.
77.
Canny G., Levy O., Furuta GT et al. Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci USA2002; 99: 3902—3907.
78.
Calafat J., Janssen H., Knol EF, Malm J., Egesten A.The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation. APMIS2000; 108: 201—208.
79.
Weiss J., Elsbach P., Olsson I., Odeberg H.Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem1978; 253: 2664—2672.
80.
Elsbach P., Weiss J., Franson RC, Beckerdite-Quagliata S., Schneider A., Harris L.Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. J Biol Chem1979; 254: 11000—11009.
81.
Gazzano-Santoro H., Parent JB, Grinna L. et al. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun1992; 60: 4754—4761.
82.
Gazzano-Santoro H., Parent JB, Conlon PJ et al. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23. Infect Immun1995; 63: 2201—2205.
83.
Ooi CE, Weiss J., Elsbach P., Frangione B., Mannion B.A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein . J Biol Chem1987; 262: 14891—14894.
84.
Ooi CE, Weiss J., Doerfler ME, Elsbach P.Endotoxin-neutralizing properties of the 25 kD N-terminal fragment of the 55—60 kD bactericidal/permeability-increasing protein of human neutrophils . J Exp Med1991; 174: 649—655.
85.
Capodici C., Chen S., Sidorczyk Z., Elsbach P., Weiss J.Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal-fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect Immun1994; 62: 259—265.
86.
Huang K., Fishwild DM, Wu H-M., Dedrick RLLipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein . Inflammation1995; 19: 389—404.
87.
Weiss J., Franson RC, Beckerdite S., Schmeidler K., Elsbach P.Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest1975; 55: 33—42.
88.
Weiss J., Muello K., Victor M., Elsbach P.The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol1984; 132: 3109—3115.
89.
Elsbach P., Weiss J.The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against Gram-negative bacteria and lipopolysaccharide. Immunobiology1993; 187: 417—429.
90.
Kartalija M. , Kim Y., White ML, Nau R., Tureen JH, Täuber MGEffect of a recombinant N-terminal fragment of bactericidal/permeability increasing protein (rBPI23) on cerebrospinal fluid inflammation induced by endotoxin. J Infect Dis1995; 171: 948—953.
Lechner AJ, Lamprech KE, Johanns CA, Matuschak GMThe recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia. Shock1995; 4: 298—306.
93.
Hansbrough J., Tenenhaus M., Wikström T. et al. Effects of recombinant bactericidal/permeability-increasing protein (rBPI23) on neutrophil activity in burned rats. J Trauma1996; 40: 886—892.
94.
Schlag G., Redl H., Davies J., Scannon P.Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties . Ann Surg1999; 229: 262—271.
95.
Wiese A., Brandenburg K., Lindner B. et al. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry1997; 36: 10301—10310.
96.
Beamer LJ, Carroll SF, Eisenberg D.Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science1997; 276: 1861—1864.
97.
Wiese A., Brandenburg K., Carroll SF, Rietschel ETh, Seydel U.Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of Gram-negative bacteria. Biochemistry1997; 36: 10311—10319.
98.
Zanetti M., Gennaro R., Romeo D.Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett1995; 374: 1—5.
99.
Cowland JB, Johnsen AH, Borregaard N.hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett1995; 368: 173—176.
100.
Malm J., Sørensen O., Persson T. et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun2000; 68: 4297—4302.
101.
Sø rensen O., Cowland JB, Askaa J., Borregaard N.An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods1997; 206: 53—59.
102.
Frohm M., Gunne H., Bergman AC et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem1996; 237: 86—92.
103.
Agerberth B., Grunewald J., Castanos-Velez E. et al. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med1999; 160: 283—290.
104.
Bals R., Wang X., Zasloff M., Wilson JMThe peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface . Proc Natl Acad Sci USA1998; 95: 9541—9546.
105.
Agerberth B., Charo J., Werr J. et al. The human antimicrobial and chemotactic peptides LL-37 and a-defensins are expressed by specific lymphocyte and monocyte populations. Blood2000; 96: 3086—3093.
106.
Conner K., Nern K., Rudisill J., O'Grady T., Gallo RLThe antimicrobial peptide LL-37 is expressed by keratinocytes in Condyloma acuminatum and Verruca vulgaris. J Am Acad Dermatol2002; 47: 347—350.
107.
Hirata M., Zhong J., Wright SC, Larrick JWStructure and functions of endotoxin-binding peptides derived from CAP18. Prog Clin Biol Res1995; 392: 317—326.
108.
de Haas CJ , Haas PJ, van Kessel KP, van Strijp JAAffinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology. Biochem Biophys Res Commun1998 ; 252: 492—496.
109.
Travis SM, Anderson NN, Forsyth WR et al. Bactericidal activity of mammalian cathelicidin-derived peptides . Infect Immun2000; 68: 2748—2755.
110.
Larrick JW , Hirata M., Shimomoura Y. et al. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother1993 ; 37: 2534—2539.
111.
Basañez G. , Shinnar AE, Zimmerberg J.Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes. FEBS Lett2002; 532: 115—120.
112.
Benz R.Uptake of solutes through bacterial outer membranes. In: Ghuysen J-M, Hakenbeck R. (eds) Bacterial Cell Wall. Amsterdam : Elsevier, 1984: 397—423.
113.
Gutsmann T. , Larrick JW, Seydel U., Wiese A.Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of Gram-negative bacteria . Biochemistry1999; 38: 13643—13653.
114.
Kaca W., Radziejewska-Lebrecht J., Bhat UREffect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis. Microbios1990; 61: 23—32.
115.
Guina T., Yi EC, Wang H., Hackett M., Miller SIA PhoPregulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol2000; 182: 4077—4086.
116.
B akker Ep , Mangerich WEInterconversion of components of the bacterial proton motive force by electrogenic potassium transport. J Bacteriol1981; 147: 820—826.
117.
Ganz T., Lehrer RIDefensins. Pharmacol Ther1995; 66: 191—205.
118.
Lehrer RI, Ganz T.Defensins of vertebrate animals. Curr Opin Immunol2002; 14: 96—102.
Harder J., Bartels J., Christophers E., Schröder JMIsolation and characterization of human p-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem2001; 276: 5707—5713.
121.
Martin E., Ganz T., Lehrer RIDefensins and other endogenous peptide antibiotics of vertebrates . J Leukoc Biol1995; 58: 128—135.
122.
Schrö der JM. Epithelial peptide antibiotics. Biochem Pharmacol1999; 57: 121—134.
123.
Ganz T.Epithelia: not just physical barriers. Proc Natl Acad Sci USA2002; 99: 3357—3358.
124.
Osborn RW, De Samblanx GW, Thevissen K. et al. Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae. FEBS Lett1995; 368: 257—262.
125.
White SH, Wimley WC, Selsted MEStructure, function, and membrane integration of defensins. Curr Opin Struct Biol1995; 5: 521—527.
126.
Sawyer JG, Martin NL, Hancock Rew.Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun1988 ; 56: 693—698.
127.
Lehrer RI, Barton A., Daher KA, Harwig Ssl, Ganz T., Selsted MEInteraction of human defensins with Escherichia coli. J Clin Invest1989; 84: 553—561.
128.
Hill CP, Yee J., Selsted ME, Eisenberg D.Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science1991 ; 251: 1481—1485.
129.
Selsted ME , Ouellette AJDefensins in granules of phagocytic and non-phagocytic cells. Trends Cell Biol1995; 5: 114—119.
130.
Kagan BL, Selsted ME, Ganz T., Lehrer RIAntimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA1990; 87: 210—214.
131.
Hristova K. , Selsted ME, White SHCritical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J Biol Chem1997; 272: 24224—24233.
132.
Storm DR, Rosenthal K.Polymyxin and related peptide antibiotics. Annu Rev Biochem1977; 46: 723—763.
133.
El Mashak EM, Tocanne JFPolymyxin B-phosphatidylglycerol interactions. A monolayer (π, Δ V) study. Biochim Biophys Acta1980; 596: 165—179.
134.
Vaara M., Vaara T.Polycations as outer membrane disorganizing agents. Antimicrob Agents Chemother1983; 24: 114—122.
135.
Hancock Rew.Alterations in outer membrane permeability . Annu Rev Microbiol1984; 38: 237—264.
136.
Vaara M.Agents that increase the permeability of the outer membrane. Microbiol Rev1992; 56: 395—411.
137.
Schindler Prg, Teuber M.Ultrastructural study of Salmonella typhimurium treated with membrane active agents: specific reaction of dansylchloride with cell envelope components. J Bacteriol1978 ; 135: 198—206.
138.
Schindler Prg, Teuber M.Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob Agents Chemother1975; 8: 95—104.
139.
Theretz A. , Theissie J., Tocanne JFA study of the structure and dynamics of complexes between polymyxin B and phosphatidylglycerol in monolayers by fluorescence . Eur J Biochem1984; 142: 113—119.
140.
Beurer G., Warncke F., Galla H-J.Interaction of polymyxin B1 and polymyxin B1 nonapeptide with phosphatidic acid monolayer and bilayer membranes. Chem Phys Lipids1988; 47: 155—163.
141.
Imai M., Inoue K., Nojima S.Effect of polymyxin B on liposomal membranes derived from Escherichia coli lipids. Biochim Biophys Acta1975; 375: 130—137.
142.
Ranck JL, Tocanne JFPolymyxin B induces interdigitation in dipalmitoylphosphatidylglycerol lamellar phase with stiff hydrocarbon chains. FEBS Lett1982; 143: 175—178.
143.
Mushayakarara E., Levin IWEffects of polypeptide-phospholipid interactions on bilayer reorganizations. Raman spectroscopic study of the binding of polymyxin B to dimyristoylphosphatidic acid and dimyristoylphosphatidylcholine dispersions . Biochim Biophys Acta1984; 769: 585—595.
144.
Sixl F., Watts A.Deuterium and phosphorous nuclear magnetic resonance studies on the binding of polymyxin B to lipid bilayer-water interfaces. Biochemistry1985; 24: 7906—7910.
145.
Feingold DS , HsuChen CC, Sud IJ. Basis for the selectivity of action of the polymyxin antibiotics on cell membranes. Ann NY Acad Sci1974; 235: 480—492.
146.
Antonov VF, Korepanova EA, Vladimirov YABilayer membranes charged by detergents as model to study the role of the surface charge in ionic permeability. Studia Biophys1976; 58: 87—101.
147.
Miller IR, Bach D., Teuber M.Effect of polymyxin B on the structure and the stability of lipid layers. J Membr Biol1978; 39: 49—56.
148.
Zhang L., Dhillon P., Yan H., Farmer S., Hancock Rew.Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother2000; 44: 3317—3321.
149.
Daugelavicius R., Bakiene E., Bamford DHStages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob Agents Chemother2000; 44: 2969—2978.
150.
Srimal S., Surolia N., Balasubramanian S., Surolia A.Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem J1996; 315: 679—686.
151.
Thomas CJ, Gangadhar BP, Surolia N., Surolia A.Kinetics and mechanism of the recognition of endotoxin by polymyxin B. J Am Chem Soc1998; 120: 12428—12434.
152.
Thomas CJ, Surolia A.Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis. FEBS Lett1999; 445: 420—424.
153.
Thomas CJ, Surolia N., Surolia A.Surface plasmon resonance studies resolve the enigmatic endotoxin neutralizing activity of polymyxin B. J Biol Chem1999; 274: 29624—29627.
154.
Kubesch P. , Boggs J., Luciano L., Maass G., Tümmler B.Interaction of polymyxin B nonapeptide with anionic phospholipids. Biochemistry1987; 26: 2139—2149.
155.
Boggs JM, Rangaraj G.Phase transitions and fatty acid spin label behavior in interdigitated lipid phases induced by glycerol and polymyxin. Biochim Biophys Acta1985; 816: 221—233.
156.
Peterson A. , Hancock Rew, McGroarty EJBinding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa . J Bacteriol1985; 164: 1256—1261.
157.
Schröder G. , Brandenburg K., Seydel U.Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/ phospholipid bilayers . Biochemistry1992; 31: 631—638.
158.
Wiese A., Münstermann M., Gutsmann T. et al. Molecular mechanisms of polymyxin B—membrane interactions: direct correlation between surface charge density and self-promoted transport . J Membr Biol1998; 162: 127—138.
159.
Vaara M., Vaara T., Jensen M. et al. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett1981; 129: 145—149.
160.
Nummila K., Kilpeläinen I., Zähringer U., Vaara M., Helander IMLipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol1995 ; 16: 271—278.
161.
Helander IM, Kato Y., Kilpeläinen I. et al. Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3. Eur J Biochem1996; 237: 272—278.
162.
Seltmann G., Lindner B., Holst O.Resistance of Serratia marcescens to polymyxin B: a comparative investigation of two S-form lipopolysaccharides obtained from a sensitive and a resistant variant of strain 111. J Endotoxin Res1996 ; 3: 497—504.
163.
Rahaman SO, Mukherjee J., Chakrabarti A., Pal S.Decreased membrane permeability in a polymyxin B-resistant Escherichia coli mutant exhibiting multiple resistance to beta-lactams as well as aminoglycosides . FEMS Microbiol Lett1998; 161: 249—254.
164.
Yethon JA, Gunn JS, Ernst RK et al. Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo. Infect Immun2000; 68: 4485—4491.
165.
Ernst RK, Guina T., Miller SIHow intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis1999; 179 (Suppl 2): S326—S330.
166.
Ernst RK, Guina T., Miller SISalmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect2001 ; 3: 1327—1334.
167.
Liechty A., Chen J., Jain MKOrigin of antibacterial stasis by polymyxin B in Escherichia coli. Biochim Biophys Acta2000; 1463: 55—64.
168.
Brodsky IE , Ernst RK, Miller SI, Falkow S.mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol2002; 184: 3203—3213.
169.
Gutsmann T. , Hagge SO, Larrick JW, Seydel U., Wiese A.Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids . Biophys J2001; 80: 2935—2945.
